Innovation, Commercialization, and Start-Ups in Life Sciences
portes grátis
Innovation, Commercialization, and Start-Ups in Life Sciences
Jordan, James F.
Taylor & Francis Ltd
09/2021
214
Dura
Inglês
9780367533038
15 a 20 dias
426
Descrição não disponível.
Chapter 1. Investment Uses a Translation Process to Deliver Innovation. Chapter 2. Investment Uses a Translation Process to Deliver Innovation. Chapter 3. The Journey of Innovation Begins with Investment. Chapter 4. The United States Helps Small Companies Conduct R&D. Chapter 5. Commercialization Is Primarily Executed through Two Organization Types. Chapter 6. Angels and Venture Capitalists Invest in Commercialization. Chapter 7. Create Liquidity for Your Investors. Chapter 8. A Liquidity Event Is Not Consummated without Due Diligence. Chapter 9. Due Diligence Reputation Is a Critical Business Process. Chapter 10. Find the Industry Norms. Chapter 11. Solve an Important Customer Problem. Chapter 12. Demonstrate the Ability to Access the Sales Channel. Chapter 13. Gather Domain-Experienced Personnel to Reduce Risk. Chapter 14. Determine the Acquirer's Strategic Future and Purchase Triggers. Chapter 15. Align an Investor's Fundable Milestones and an Acquirer's Exit Points. Chapter 16. Create an IP Pyramid for Impervious Positioning. Chapter 17. Address Your Story to the Needs of All Constituencies. Chapter 18. Deliver to Your Plan. Chapter 19. Tell a Compelling Story with the Investor Pitch. Chapter 20. Continuously Improve Your Message with the Plan-Do-Check-Act Cycle. Appendix 1. Notes.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Investment Uses a Translation Process to Deliver Innovation;Part 1 - Innovation is a Process of Connected Steps;Part 2 - Investment Must Be Connected to Exit;Part 3 - Align With the Industry Norms;Part 4 - A Startup Must Tell a Compelling Story;Corporate Venture Capital;Small Business Technology Transfer Programs;ROI;SBIR Grant;Fundable Milestones;SBIR Program;Connected Steps;Life Science Start Ups;Non-dilutive Funding;Due Diligence Checklist;Investor Pitch;Life Sciences;Product Life Cycle Curve;Blue Belt;Venture Capital;Business Process;Due Diligence Process;Purchase Triggers;Company IP;Due Diligence Organization;Life Science Companies;POCT;Health Care Information Technology;Commercialization Plan;Corporate Venture
Chapter 1. Investment Uses a Translation Process to Deliver Innovation. Chapter 2. Investment Uses a Translation Process to Deliver Innovation. Chapter 3. The Journey of Innovation Begins with Investment. Chapter 4. The United States Helps Small Companies Conduct R&D. Chapter 5. Commercialization Is Primarily Executed through Two Organization Types. Chapter 6. Angels and Venture Capitalists Invest in Commercialization. Chapter 7. Create Liquidity for Your Investors. Chapter 8. A Liquidity Event Is Not Consummated without Due Diligence. Chapter 9. Due Diligence Reputation Is a Critical Business Process. Chapter 10. Find the Industry Norms. Chapter 11. Solve an Important Customer Problem. Chapter 12. Demonstrate the Ability to Access the Sales Channel. Chapter 13. Gather Domain-Experienced Personnel to Reduce Risk. Chapter 14. Determine the Acquirer's Strategic Future and Purchase Triggers. Chapter 15. Align an Investor's Fundable Milestones and an Acquirer's Exit Points. Chapter 16. Create an IP Pyramid for Impervious Positioning. Chapter 17. Address Your Story to the Needs of All Constituencies. Chapter 18. Deliver to Your Plan. Chapter 19. Tell a Compelling Story with the Investor Pitch. Chapter 20. Continuously Improve Your Message with the Plan-Do-Check-Act Cycle. Appendix 1. Notes.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Investment Uses a Translation Process to Deliver Innovation;Part 1 - Innovation is a Process of Connected Steps;Part 2 - Investment Must Be Connected to Exit;Part 3 - Align With the Industry Norms;Part 4 - A Startup Must Tell a Compelling Story;Corporate Venture Capital;Small Business Technology Transfer Programs;ROI;SBIR Grant;Fundable Milestones;SBIR Program;Connected Steps;Life Science Start Ups;Non-dilutive Funding;Due Diligence Checklist;Investor Pitch;Life Sciences;Product Life Cycle Curve;Blue Belt;Venture Capital;Business Process;Due Diligence Process;Purchase Triggers;Company IP;Due Diligence Organization;Life Science Companies;POCT;Health Care Information Technology;Commercialization Plan;Corporate Venture
